Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled furosemide for transient tachypnoea of the newborn
2011-003473-29Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in transient tachypnea of the newborn (TTN) comparing Nebulized furosemide with Nebulized saline placebo (2 arms). Primary endpoint: Change in Silverman score after inhalation of trial drug. Started Jul 2012; status: completed.
02
Drugs
furosemide
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on 2011-003473-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003473-29.